Cite
Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice
MLA
Berlo, S. E., et al. Increased Arthritis Susceptibility in Cartilage Proteoglycan-Specific T Cell Receptor-Transgenic Mice. Jan. 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........e6b2c284f7e13539e96b5e4a2fac4cd6&authtype=sso&custid=ns315887.
APA
Berlo, S. E., Guichelaar, T., ten Brink, C. B. M., van Kooten, P. J., Hauet-Broere, F., Ludanyi, K., van Eden, W., Broeren, C. P. M., Glant, T., Risk Assessment of Toxic and Immunomodulatory Agents, Strategic Infection Biology, & Dep Infectieziekten Immunologie. (2006). Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
Chicago
Berlo, S.E., T. Guichelaar, C.B.M. ten Brink, P.J. van Kooten, F. Hauet-Broere, K. Ludanyi, W. van Eden, et al. 2006. “Increased Arthritis Susceptibility in Cartilage Proteoglycan-Specific T Cell Receptor-Transgenic Mice,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........e6b2c284f7e13539e96b5e4a2fac4cd6&authtype=sso&custid=ns315887.